Possible Short Squeeze in $rgc
Post# of 6705
(Total Views: 219)
Posted On: 08/10/2022 12:55:42 AM
Stocks with high short interest are often very volatile and are well known for making explosive upside moves (known as a short squeeze). Stock traders will often flock to such stocks for no reason other than the fact that they have a high short interest and the price can potentially move up very quickly as traders with open short positions move to cover.
"The possibility of a short squeeze is one reason some analysts look at a high amount of short interest as a bullish indicator. Short Interest is the fuel, performance is the fuse, says ShortSqueeze.com"
- USA Today
Both $RGC and $GME's short volume ratios, which have averaged over 40% over the past year, follow a similar pattern. In fact, there have been days when Regencell's shares have been shorted about 90% more than GameStop. It should be noted that, in comparison to GME, RGC has a very low float.
If two companies both have 25% short float, but one has 10M unshorted shares floating and the other has 200M unshorted shares floating, the first one is clearly more susceptible to a short squeeze. The effect of this change is that the updated model will favor low-float companies over others, all other things being equal.
Little shares of $RGC are also available for shorting, but it appears that more shares have been sold short than are currently available.
Regencell’s total cumulative short volume, as reported by a third-party data analytics provider, is over 19 million shares, while the total outstanding shares less CEO and Chairman’s shares is only approximately 2.4 million, yet Regencell is still trading over 289% its IPO price. Its total reported short volume to outstanding shares ratio (excluding CEO and Chairman’s shares ratio) is almost double of GameStop, being approximately 8 times whereas GameStop is slightly over 4 times. GameStop is currently trading 50x over its historical low of $2.52. Where are all the extra shares coming from?
https://www.benzinga.com/general/biotech/22/0...rs-short-i
https://fintel.io/shortSqueeze
HighShortInterest.com
"The possibility of a short squeeze is one reason some analysts look at a high amount of short interest as a bullish indicator. Short Interest is the fuel, performance is the fuse, says ShortSqueeze.com"
- USA Today
Both $RGC and $GME's short volume ratios, which have averaged over 40% over the past year, follow a similar pattern. In fact, there have been days when Regencell's shares have been shorted about 90% more than GameStop. It should be noted that, in comparison to GME, RGC has a very low float.
If two companies both have 25% short float, but one has 10M unshorted shares floating and the other has 200M unshorted shares floating, the first one is clearly more susceptible to a short squeeze. The effect of this change is that the updated model will favor low-float companies over others, all other things being equal.
Little shares of $RGC are also available for shorting, but it appears that more shares have been sold short than are currently available.
Regencell’s total cumulative short volume, as reported by a third-party data analytics provider, is over 19 million shares, while the total outstanding shares less CEO and Chairman’s shares is only approximately 2.4 million, yet Regencell is still trading over 289% its IPO price. Its total reported short volume to outstanding shares ratio (excluding CEO and Chairman’s shares ratio) is almost double of GameStop, being approximately 8 times whereas GameStop is slightly over 4 times. GameStop is currently trading 50x over its historical low of $2.52. Where are all the extra shares coming from?
https://www.benzinga.com/general/biotech/22/0...rs-short-i
https://fintel.io/shortSqueeze
HighShortInterest.com
(0)
(0)